Company Filing History:
3 out of 41 
1 out of 13 
1 out of 1 Years Active: 2016-2025
Title: Innovations and Contributions of Inventor Xiaowen Chen
Introduction
Xiaowen Chen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating schizophrenia. With a total of 3 patents, his work showcases a commitment to advancing medical science.
Latest Patents
Xiaowen Chen's latest patents include a pyridinyl morpholine compound, along with its preparation method and application. This invention provides a compound that can be utilized as an antagonist for dopamine and serotonin receptors, which is essential in developing drugs for treating schizophrenia. Another significant patent involves benzoisothiazole compounds, which are also aimed at preparing anti-schizophrenia drugs. These compounds demonstrate a strong affinity for dopamine and serotonin receptors, showing promise in improving symptoms related to schizophrenia with good oral absorption and minimal side effects.
Career Highlights
Throughout his career, Xiaowen Chen has worked with reputable organizations such as the Shanghai Institute of Pharmaceutical Industry and Nhwa Pharmaceutical Corporation. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the pharmaceutical sector.
Collaborations
Xiaowen Chen has collaborated with esteemed colleagues, including Jianqi Li and Guan Zhong Wang. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Xiaowen Chen's contributions to the field of pharmaceuticals, particularly in the treatment of schizophrenia, highlight his role as an influential inventor. His innovative patents and collaborations reflect a dedication to improving mental health treatments.